Latest publications
Temozolomide-induced RNA interactome uncovers novel lncRNA regulatory loops in glioblastoma.
- NORLUX Neuro-Oncology Laboratory
- Quantitative Biology Unit
- DNA Repair and Chemoresistance
2020 Sep. Cancers.12(9).
A DNA repair and cell-cycle gene expression signature in primary and recurrent glioblastoma: prognostic value and clinical implications.
- DNA Repair and Chemoresistance
- Computational Biomedicine
- NORLUX Neuro-Oncology Laboratory
2019 Mar. Cancer Res.79(6):1226-1238. Epub 2019 Jan 23.
Targeted DNA repair gene expression study in glioblastoma patient biopsies: clinical impact and characterisation of the NEIL3 DNA glycosylase, a novel candidate target for therapy. (Doctoral thesis)
- DNA Repair and Chemoresistance
2019 Mar. Luxembourg: Université de Luxembourg 2019. 156 p.
Centromeric and ectopic assembly of CENP-A chromatin in health and cancer: old marks and new tracks.
- DNA Repair and Chemoresistance
2019 Feb. Nucleic Acids Res.47(3):1051-1069.
RNAi/CRISPR Screens: from a Pool to a Valid Hit.
- NORLUX Neuro-Oncology Laboratory
- Computational Biomedicine
- DNA Repair and Chemoresistance
2019 Jan. Trends Biotechnol.37(1):38-55. Epub 2018 Aug 31.
Sensitizing Ewing sarcoma to chemo- and radiotherapy by inhibition of the DNA-repair enzymes DNA protein kinase (DNA-PK) and poly-ADP-ribose polymerase (PARP) 1/2.
- DNA Repair and Chemoresistance
2017 Dec. Oncotarget.8(69):113418-113430.
Identification of DNA damage response genes as targets for personalised treatment of Glioblastoma through RNA interference screens. (Doctoral thesis)
- DNA Repair and Chemoresistance
2017 Sep. Luxembourg: Université de Luxembourg, 2017.
DNA repair mechanisms and their clinical impact in glioblastoma.
- DNA Repair and Chemoresistance
- NORLUX Neuro-Oncology Laboratory
2016 Jul. Mutat Res Rev Mutat Res.769:19-35. Epub 2016 Jun 21.
Maximizing the efficacy of MAPK-targeted treatment in PTENLOF/BRAFMUT melanoma through PI3K and IGF1R inhibition.
- DNA Repair and Chemoresistance
2016 Jan. Cancer Res.76(2):390-402. Epub 2015 Nov 17.
The pH sensibility of actin-bundling LIM proteins is governed by the acidic properties of their C-terminal domain.
- Cytoskeleton and Cancer Progression
- NORLUX Neuro-Oncology Laboratory
- DNA Repair and Chemoresistance
2015 Aug. FEBS Lett.589(18):2312-9. Epub 2015 Jul 29.